Plain-English translation of NCT04746820 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether a special brain scan called functional near-infrared spectroscopy (fNIRS) can help doctors predict how well patients will recover after a severe stroke or cardiac arrest. Right now, doctors use other tests and clinical observations to make these predictions, but they aren't always reliable. Researchers want to see if this new scan — which is non-invasive, quick, and can be done at the bedside — might be better at predicting recovery.
When patients suffer severe strokes or cardiac arrests, doctors need reliable ways to predict early on whether they will wake up and recover. Better predictions help families make informed decisions about care and help doctors plan the right treatment path. This medication aims to fill that gap by offering a simple, accurate bedside test.
You likely qualify if…
You likely don't qualify if…
If you are in the unconscious patient group, you will receive the fNIRS brain scan at your bedside in the intensive care unit — it is painless and non-invasive. Researchers will also compare your scan results to standard tests (like evoked potentials) that doctors already use to predict recovery. The study will also include healthy volunteers who receive the same scan so researchers can compare results. The entire process is designed to take place within your first week in the hospital.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
Switzerland